semaglutide and ovulation metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized trial Women with a common hormonal

Have you started a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Saxenda and noticed changes in your skin

The medication already slows how quickly food leaves your stomach dramatically increasing fiber all at once can intensify GI side effects

In November, the FDA approved Zepbound as a weight loss management treatment for people with obesity, or those who are overweight with at least one related underlying condition, such as high blood pressure

Pairs with the Szeto SS-31 nephrology work as a useful comparator across the metabolic vs mitochondrial mechanism axes

You're increasing the sensitivity of those

In the ATTAIN-1 trial, adverse events led to treatment discontinuation in up to 10.3 percent of patients on the drug, compared to only 2.7 percent on placebo